Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours

This publication has 24 references indexed in Scilit:

• A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy
  Oncology, 1998
• Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration
  Cancer Chemotherapy and Pharmacology, 1998
• Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer
  Annals of Oncology, 1998
• Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.
  Journal of Clinical Oncology, 1998
• Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
  Journal of Clinical Oncology, 1998
• A phase I trial of ifosfamide and paclitaxel with granulocyte‐colony stimulating factor in the treatment of patients with refractory solid tumors
  Cancer, 1998
• A feasibility study of 1-h paclitaxel infusion in patients with solid tumors
  Cancer Chemotherapy and Pharmacology, 1997
• Accelerated chemotherapy for poor prognosis germ cell tumours
  European Journal Of Cancer, 1994
• Taxol: A novel radiation sensitizer
  International Journal of Radiation Oncology*Biology*Physics, 1992
• The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo
  Biochemical Pharmacology, 1989